Skip to main content
European Commission logo
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS

Novel small molecule activators of the NLRP3 inflammasome as immunostimulants

Obiettivo

We have identified a novel family of potent small molecule activators of the NLRP3 inflammasome. The goal of this project is to determine the feasibility of developing these new immunostimulators into an attractive commercial proposition. Establishment of technical feasibility will involve identification the most promising modifications of our drug candidates and testing their efficacy in disease models of cancer and immunization. In addition, we will determine commercial feasibility by conducting market research and competition analysis and by engaging potential industry partners.

Meccanismo di finanziamento

ERC-POC - Proof of Concept Grant

Istituzione ospitante

UNIVERSITAETSKLINIKUM FREIBURG
Contribution nette de l'UE
€ 150 000,00
Indirizzo
HUGSTETTER STRASSE 49
79106 Freiburg
Germania

Mostra sulla mappa

Regione
Baden-Württemberg Freiburg Freiburg im Breisgau, Stadtkreis
Tipo di attività
Higher or Secondary Education Establishments
Collegamenti
Costo totale
Nessun dato

Beneficiari (1)